Drug Search Results
More Filters [+]

Docarpamine

Alternative Names: docarpamine
Latest Update: 2024-12-03
Latest Update Note: News Article

Product Description

Mechanisms of Action: DR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Martin Pharmaceuticals
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Docarpamine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Liver Cirrhosis|Intestinal Diseases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

DREAM

P2

Terminated

Liver Cirrhosis|Intestinal Diseases

2023-07-28

Recent News Events